PAB is a great little company and the fundamentals appear...

PAB is a great little company and the fundamentals appear stronger than they have been previously however its a slow and frustrating process to get to where we all want it to be.

After holding PAB for over 7 years it is clear that a sustained SP rise is only possible once we reach clinical trials (with positive results) or we have some form of partnering or interest from major pharma to re-rate the stock. The other alternative may be a takeover but I doubt that would happen. Until then I wouldn't be surprised to see it drift toward 1 cent which is a good thing for those who believe and want to top up their coffers.